Epocrates Inc., a vendor of software to access drug reference information via mobile computing devices, has filed a registration statement with the Securities and Exchange Commission to sell up to $75 million in a public offering of stock.
The San Mateo, Calif.-based company plans to use proceeds to pay $27.2 million in dividends to preferred Series B stockholders, and for general corporate purposes that could include acquisitions. The company is developing an "affordable" electronic health records system for solo and small physician practices.
Register or login for access to this item and much more
All Health Data Management content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access